Biomerica (BMRA) EBITDA Margin Growth (3y) (2013 - 2026)
Biomerica (BMRA) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 1,505.00 |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -184.00 |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | -3,846.00 |
| 10 | Biomerica | 6.20 Mn | 4.87 Mn | -44,000.00 | 1,694.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1,694.00 |
| Nov 30, 2025 | 115.00 |
| Aug 31, 2025 | 12,766.00 |
| May 31, 2025 | -17,165.00 |
| Feb 28, 2025 | -10,263.00 |
| Nov 30, 2024 | -3,400.00 |
| Aug 31, 2024 | 4,952.00 |
| May 31, 2024 | 3,497.00 |
| Feb 29, 2024 | -12,970.00 |
| Nov 30, 2023 | 2,912.00 |
| Aug 31, 2023 | 9,984.00 |
| May 31, 2023 | -13,141.00 |
| Feb 28, 2023 | -7,663.00 |
| Nov 30, 2022 | -7,982.00 |
| Aug 31, 2022 | -8,469.00 |
| May 31, 2022 | 3,419.00 |
| Feb 28, 2022 | 5,255.00 |
| Nov 30, 2021 | 778.00 |
| Aug 31, 2021 | -8,708.00 |
| May 31, 2021 | -10,289.00 |